TearLab Corporation Company Profile (NASDAQ:TEAR)

About TearLab Corporation

TearLab Corporation logoTearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TEAR
  • CUSIP:
Key Metrics:
  • Previous Close: $0.50
  • 50 Day Moving Average: $0.5874
  • 200 Day Moving Average: $0.6176
  • 52-Week Range: $0.39 - $0.97
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.19
  • P/E Growth: -0.0400
  • Market Cap: $26.99M
  • Outstanding Shares: 53,601,000
  • Beta: 2.82
Profitability:
  • Net Margins: -88.52%
  • Return on Assets: -84.48%
Debt:
  • Debt-to-Equity Ratio: -7.16%
  • Current Ratio: 4.65%
  • Quick Ratio: 4.00%
Additional Links:
Companies Related to TearLab Corporation:

Analyst Ratings

Consensus Ratings for TearLab Corporation (NASDAQ:TEAR) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.08 (313.69% upside)

Analysts' Ratings History for TearLab Corporation (NASDAQ:TEAR)
Show:
DateFirmActionRatingPrice TargetDetails
11/8/2016HC WainwrightSet Price TargetBuy$2.00View Rating Details
10/15/2016Rodman & RenshawReiterated RatingBuy$2.00View Rating Details
8/4/2016Roth CapitalDowngradeBuy -> NeutralView Rating Details
5/5/2016Feltl & Co.UpgradeBuy -> Strong-BuyView Rating Details
3/9/2016Canaccord GenuityReiterated RatingBuyView Rating Details
11/6/2015Craig HallumLower Price TargetBuy$5.00 -> $4.00View Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for TearLab Corporation (NASDAQ:TEAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2017        
11/7/2016Q316($0.08)($0.07)$7.13 million$20.90 millionViewListenView Earnings Details
8/3/2016Q2($0.08)($0.08)$6.95 million$6.90 millionViewN/AView Earnings Details
5/4/2016Q1($0.23)($0.21)$6.53 million$6.80 millionViewN/AView Earnings Details
3/8/2016Q4($0.25)($0.26)$6.83 million$6.80 millionViewN/AView Earnings Details
11/5/2015Q315($0.24)($0.24)$6.40 million$6.60 millionViewN/AView Earnings Details
8/6/2015Q215($0.25)($0.24)$5.72 million$6.30 millionViewN/AView Earnings Details
5/7/2015Q115($0.21)($0.25)$5.40 million$5.40 millionViewN/AView Earnings Details
3/12/2015Q414($0.17)($0.21)$5.50 million$5.30 millionViewN/AView Earnings Details
11/5/2014Q214($0.17)($0.17)$5.50 million$5.20 millionViewN/AView Earnings Details
8/7/2014Q114($0.16)($0.17)$5.12 million$9.20 millionViewN/AView Earnings Details
5/8/2014Q1($0.14)($0.17)$4.76 million$4.21 millionViewN/AView Earnings Details
3/13/2014Q413($0.13)($0.13)$4.49 million$4.40 millionViewN/AView Earnings Details
11/12/2013Q3($0.14)($0.13)$3.80 million$4.20 millionViewListenView Earnings Details
5/13/2013Q1 2013($0.12)($0.30)$2.18 million$2.47 millionViewN/AView Earnings Details
11/13/2012Q312($0.11)($0.10)$1.20 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for TearLab Corporation (NASDAQ:TEAR)
Current Year EPS Consensus Estimate: $-0.4400 EPS
Next Year EPS Consensus Estimate: $-0.2300 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.24)($0.22)($0.23)
Q2 20163($0.11)($0.06)($0.09)
Q3 20163($0.10)($0.08)($0.09)
Q4 20163($0.09)($0.08)($0.09)
Q1 20171($0.05)($0.05)($0.05)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.05)($0.05)($0.05)
Q4 20171($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for TearLab Corporation (NASDAQ:TEAR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for TearLab Corporation (NASDAQ:TEAR)
Insider Ownership Percentage: 11.60%
Institutional Ownership Percentage: 36.09%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/31/2016Brock WrightDirectorBuy59,686$0.78$46,555.08View SEC Filing  
5/26/2016Brock WrightDirectorBuy130,314$0.76$99,038.64View SEC Filing  
12/4/2014Elias VamvakasCEOBuy50,000$2.24$112,000.00View SEC Filing  
11/18/2014Elias VamvakasCEOBuy31,187$2.55$79,526.85View SEC Filing  
11/17/2014Elias VamvakasCEOBuy18,813$2.55$47,973.15View SEC Filing  
11/11/2014Elias VamvakasCEOBuy150,000$2.49$373,500.00View SEC Filing  
11/10/2014Elias VamvakasCEOBuy16,276$2.50$40,690.00View SEC Filing  
11/10/2014Joseph JensenCOOBuy43,375$2.31$100,196.25View SEC Filing  
8/20/2014Brock WrightDirectorBuy23,000$3.82$87,860.00View SEC Filing  
8/19/2014Brock WrightDirectorBuy11,354$3.83$43,485.82View SEC Filing  
8/12/2014Elias VamvakasCEOBuy70,000$3.43$240,100.00View SEC Filing  
6/30/2014Richard LindstromDirectorSell5,000$4.61$23,050.00View SEC Filing  
5/13/2014Elias VamvakasCEOBuy30,000$3.99$119,700.00View SEC Filing  
5/13/2014Joseph JensenCOOBuy48,693$4.11$200,128.23View SEC Filing  
4/1/2014Paul KarpeckiDirectorSell5,000$6.83$34,150.00View SEC Filing  
1/2/2014Paul KarpeckiDirectorSell5,000$9.47$47,350.00View SEC Filing  
12/31/2013Richard LindstromDirectorSell5,000$9.26$46,300.00View SEC Filing  
11/15/2013Richard LindstromDirectorSell5,000$8.95$44,750.00View SEC Filing  
10/11/2013Paul KarpeckiDirectorSell5,000$10.96$54,800.00View SEC Filing  
9/3/2013William DumencuCFOSell7,000$13.22$92,540.00View SEC Filing  
8/1/2013William DumencuCFOSell7,000$14.39$100,730.00View SEC Filing  
7/1/2013Paul KarpeckiDirectorSell5,000$10.62$53,100.00View SEC Filing  
7/1/2013William DumencuCFOSell7,000$10.61$74,270.00View SEC Filing  
6/3/2013William DumencuCFOSell7,000$11.35$79,450.00View SEC Filing  
4/2/2013Tom Jr. DavidsonDirectorBuy1,500$6.63$9,945.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for TearLab Corporation (NASDAQ:TEAR)
DateHeadline
News IconUnder the Lens: Stock Review for TearLab Corporation (NASDAQ:TEAR) - Midway Monitor (NASDAQ:TEAR)
midwaymonitor.com - February 21 at 4:46 PM
finance.yahoo.com logoTearLab Corporation to Report Fourth Quarter and Full-year 2016 Financial Results on March 9, 2017 (NASDAQ:TEAR)
finance.yahoo.com - February 21 at 4:46 PM
streetinsider.com logoForm 5 TearLab Corp For: Dec 31 Filed by: Wright Brock - StreetInsider.com (NASDAQ:TEAR)
www.streetinsider.com - February 15 at 6:25 AM
investornewswire.com logoConsensus Rating Of TearLab Corporation (NASDAQ:TEAR) At 1.5 - Investor Newswire (NASDAQ:TEAR)
www.investornewswire.com - February 13 at 8:44 PM
finance.yahoo.com logoTearLab Provides Update on International Market Milestones - Yahoo Finance (NASDAQ:TEAR)
finance.yahoo.com - February 13 at 3:39 PM
News IconStock Update: Levels in Review for TearLab Corporation (TEAR) - Piedmont Register (NASDAQ:TEAR)
piedmontregister.com - February 9 at 6:02 AM
News IconInvesting Focus: Indicators in View on Shares of TearLab Corporation (TEAR) - Sherwood Daily (NASDAQ:TEAR)
sherwooddaily.com - February 3 at 6:12 AM
News IconFocusing on the Numbers for TearLab Corporation (TLB.TO) - Rives Journal (NASDAQ:TEAR)
rivesjournal.com - February 3 at 6:12 AM
News IconEye defer to you: FCA affirms refusal of interlocutory injunction in patent suit involving ophthalmic medical devices (NASDAQ:TEAR)
www.nortonrosefulbright.com - February 2 at 5:52 AM
News IconTearLab Receives Mexican Regulatory Approval for Osmolarity System (NASDAQ:TEAR)
www.optometryweb.com - February 2 at 5:52 AM
News IconEye Defer To You: FCA Affirms Refusal Of Interlocutory Injunction In Patent Suit Involving Ophthalmic Medical Devices - Mondaq News Alerts (registration) (NASDAQ:TEAR)
www.mondaq.com - February 1 at 6:53 AM
News IconAt the Focal Point, Checking in on TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - February 1 at 6:53 AM
News IconCombating dry eye with punctal plugs (NASDAQ:TEAR)
optometrytimes.modernmedicine.com - January 28 at 6:53 AM
News IconMexican Health Authority Green Lights TearLab’s (TEAR) Osmolarity System (NASDAQ:TEAR)
galaxystocks.com - January 26 at 6:17 AM
finance.yahoo.com logoTearLab Osmolarity System Receives Mexican Regulatory Approval (NASDAQ:TEAR)
finance.yahoo.com - January 26 at 6:17 AM
finance.yahoo.com logo7:05 am TearLab receives approval for the TearLab Osmolarity System from the Comisin Federal para la Proteccin contra Riesgos Sanitarios in Mexico (NASDAQ:TEAR)
finance.yahoo.com - January 26 at 6:17 AM
News IconMonitoring Relative Strength Index Values for TearLab Corporation (TEAR) - Sherwood Daily (NASDAQ:TEAR)
sherwooddaily.com - January 21 at 3:11 AM
News IconTearLab Corporation (TEAR) Under Analyst Spotlight - UK Market News (NASDAQ:TEAR)
www.ukmarketnews.co.uk - January 17 at 10:46 AM
News IconGrowth Story Unfolding for TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - January 17 at 10:46 AM
News IconTearLab Corporation TEAR Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:TEAR)
www.bioportfolio.com - January 16 at 7:56 PM
News IconMarkets End Mostly Higher, How Did This Stock Fare: TearLab Corporation (NASDAQ:TEAR) - Wall Street Beacon (NASDAQ:TEAR)
wsbeacon.com - January 14 at 8:14 PM
News IconAre Institutions Jumping Ship on TearLab Corporation (NASDAQ:TEAR) - Wall Street Beacon (NASDAQ:TEAR)
wsbeacon.com - January 14 at 6:30 AM
News IconWill The Needle Move For TearLab Corporation (NASDAQ:TEAR) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:TEAR)
wsbeacon.com - January 14 at 6:30 AM
reuters.com logoBRIEF-Mathew Arens reports 6.6 pct passive stake in Tearlab Corp (NASDAQ:TEAR)
www.reuters.com - January 12 at 2:20 AM
investornewswire.com logoSentiments And Ratings Alert: TearLab Corporation (NASDAQ:TEAR) - Investor Newswire (NASDAQ:TEAR)
www.investornewswire.com - January 6 at 6:03 AM
News IconIs This The Right Stock For Heady Investors: TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - January 6 at 6:03 AM
News IconPrimed for Breakout or Bust? A look at TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - January 4 at 6:06 AM
News IconStock ready to Pivot? Focus on Shares of TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - January 4 at 6:06 AM
stocksdaily.net logoTearLab Corporation (NASDAQ:TEAR) FY2016 EPS Projection At $-0.25 - Stocks Daily (NASDAQ:TEAR)
www.stocksdaily.net - January 1 at 8:04 AM
News IconAre the Technicals Adding up for TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - December 31 at 3:54 AM
News IconAre Discerning Investors Interested in These Shares: TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - December 30 at 1:07 AM
News IconPrepping for a Big Move? Share Update on TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - December 23 at 8:56 PM
News IconInvestors Keen on a Bargain are Looking at TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - December 22 at 4:02 AM
investornewswire.com logoTearLab Corporation (NASDAQ:TEAR) Records An Impact Score Of 0 - Investor Newswire (NASDAQ:TEAR)
www.investornewswire.com - December 22 at 4:02 AM
News IconVC Score in Review for TearLab Corporation (NASDAQ:TEAR ... - Business Daily Leader (NASDAQ:TEAR)
businessdailyleader.com - December 22 at 4:02 AM
News IconNotable Stock For Under $5: TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - December 20 at 8:16 PM
News IconLive Chart Canada Stock Pattern Coverage: TearLab Corp (TLB) Is Yet to See Trading Action on Dec 20 - Herald KS (NASDAQ:TEAR)
heraldks.com - December 20 at 8:16 PM
News IconCompany in Focus: TearLab Corporation (NASDAQ:TEAR) - OIB News (NASDAQ:TEAR)
oibnews.com - December 14 at 8:40 PM
News IconInvestor Focus: Watching Shares of TearLab Corporation (NASDAQ:TEAR) - Liberty News (NASDAQ:TEAR)
libertynewsrecord.com - December 14 at 3:26 PM
News IconCompany Watch for TearLab Corporation (NASDAQ:TEAR) - OIB News (NASDAQ:TEAR)
oibnews.com - December 13 at 1:23 AM
News IconTop Stock With Upside & Growth Potential: TearLab Corporation (NASDAQ:TEAR) - Prospect Journal (NASDAQ:TEAR)
prospectjournal.com - December 13 at 1:23 AM
News IconLooking at the Numbers for TearLab Corporation (NASDAQ:TEAR) - Wall Street Beacon (NASDAQ:TEAR)
wsbeacon.com - December 9 at 8:03 PM
capitalcube.com logoETFs with exposure to TearLab Corp. : December 9, 2016 (NASDAQ:TEAR)
www.capitalcube.com - December 9 at 8:03 PM
News IconMarket Scope: Taking a Look at TearLab Corporation (NASDAQ:TEAR) - Liberty News (NASDAQ:TEAR)
libertynewsrecord.com - December 9 at 9:56 AM
News IconTrading Radar: Zooming in on Shares of TearLab Corporation (TLB.TO) - Wall Street Confidential (NASDAQ:TEAR)
wsconfidential.com - December 9 at 9:56 AM
News IconEV in Focus on Shares of TearLab Corporation (NASDAQ:TEAR) - Liberty News (NASDAQ:TEAR)
libertynewsrecord.com - December 7 at 8:16 AM
News IconEnterprise Value Review for TearLab Corporation (NASDAQ:TEAR) - OIB News (NASDAQ:TEAR)
oibnews.com - December 6 at 8:13 AM
News IconCanada Worth Watching: TearLab Corp (TLB) Plunges -6.94% on Dec 5 - Herald KS (NASDAQ:TEAR)
heraldks.com - December 6 at 8:13 AM
News IconTear osmolarity provides data on level of ocular stress (NASDAQ:TEAR)
www.healio.com - December 2 at 3:19 PM
News IconValue Score in View for TearLab Corporation (NASDAQ:TEAR) - OIB News (NASDAQ:TEAR)
oibnews.com - December 1 at 8:02 PM

Social

What is TearLab Corporation's stock symbol?

TearLab Corporation trades on the NASDAQ under the ticker symbol "TEAR."

Where is TearLab Corporation's stock going? Where will TearLab Corporation's stock price be in 2017?

5 equities research analysts have issued 1 year price targets for TearLab Corporation's shares. Their predictions range from $2.00 to $2.25. On average, they expect TearLab Corporation's stock price to reach $2.08 in the next twelve months.

When will TearLab Corporation announce their earnings?

TearLab Corporation is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.

Who owns TearLab Corporation stock?

TearLab Corporation's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Mathew P Aren (6.60%) and First Light Asset Management LLC (6.27%).

Who sold TearLab Corporation stock? Who is selling TearLab Corporation stock?

TearLab Corporation's stock was sold by a variety of institutional investors in the last quarter, including First Light Asset Management LLC.

How do I buy TearLab Corporation stock?

Shares of TearLab Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of TearLab Corporation stock cost?

One share of TearLab Corporation stock can currently be purchased for approximately $0.50.

TearLab Corporation (NASDAQ:TEAR) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for TearLab Corporation (NASDAQ:TEAR)

Earnings History Chart

Earnings by Quarter for TearLab Corporation (NASDAQ:TEAR)

Dividend History Chart

Dividend Payments by Quarter for TearLab Corporation (NASDAQ:TEAR)

Last Updated on 2/23/2017 by MarketBeat.com Staff